tiprankstipranks
Trending News
More News >
BioMarin Pharmaceutical (DE:BM8)
FRANKFURT:BM8
Germany Market

BioMarin Pharmaceutical (BM8) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
2Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
BioMarin Pharmaceutical’s (BM8) Moving Averages Convergence Divergence (MACD) indicator is 0.21, suggesting BioMarin Pharmaceutical is a Sell.
BioMarin Pharmaceutical’s (BM8) 20-Day exponential moving average is 48.49, while BioMarin Pharmaceutical’s (BM8) share price is €50.4, making it a Buy.
BioMarin Pharmaceutical’s (BM8) 50-Day exponential moving average is 48.13, while BioMarin Pharmaceutical’s (BM8) share price is €50.4, making it a Buy.

BioMarin Pharmaceutical (BM8) Pivot Points

Feb 13, 2026, 08:26 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
48.30
48.30
48.30
48.30
48.30
48.30
48.30
Fibonacci
48.30
48.30
48.30
48.30
48.30
48.30
48.30
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BioMarin Pharmaceutical (BM8) Moving Averages

Feb 13, 2026, 08:26 AM
Period
Simple
Exponential
MA5
48.96Buy
49.14Buy
MA10
48.37Buy
48.72Buy
MA20
48.07Buy
48.49Buy
MA50
48.08Buy
48.13Buy
MA100
47.11Buy
48.21Buy
MA200
48.41Buy
50.38Buy
BioMarin Pharmaceutical’s (BM8) 10-Day exponential moving average is 48.72, while BioMarin Pharmaceutical’s (BM8) share price is €50.4, making it a Buy.
BioMarin Pharmaceutical’s (BM8) 100-Day exponential moving average is 48.21, while BioMarin Pharmaceutical’s (BM8) share price is €50.4, making it a Buy.
BioMarin Pharmaceutical’s (BM8) stock price is €50.4 and BioMarin Pharmaceutical’s (BM8) 50-day simple moving average is 48.08, creating a Buy signal.
BioMarin Pharmaceutical’s (BM8) stock price is €50.4 and BioMarin Pharmaceutical’s (BM8) 100-day simple moving average is 47.11, creating a Buy signal.
BioMarin Pharmaceutical’s (BM8) stock price is €50.4 and BioMarin Pharmaceutical’s (BM8) 200-day simple moving average is 48.41, creating a Buy signal.

BioMarin Pharmaceutical (BM8) Technical Indicators

Feb 13, 2026, 08:26 AM
Name
Value
Implied Action
RSI (14)
57.45
Neutral
STOCH (9,6)
82.26
Sell
STOCHRSI (14)
82.26
Sell
MACD (12,26)
0.21
Sell
ADX (14)
13.26
Buy
Williams %R
0.00
Sell
CCI (14)
181.15
Sell
ATR (14)
1.08
-
Ultimate Oscillator
63.46
Neutral
ROC
3.09
Buy
BioMarin Pharmaceutical’s (BM8) Relative Strength Index (RSI) is 57.45, creating a Neutral signal.
BioMarin Pharmaceutical’s (BM8) Trend Strength Indicator (ADX) is 13.26, creating a Buy signal.
BioMarin Pharmaceutical’s (BM8) Commodity Channel Index (CCI) is 181.15, creating a Sell signal.
BioMarin Pharmaceutical’s (BM8) Price Rate of Change (ROC) is 3.09, creating a Buy signal.

FAQ

Is BM8 a Buy, Hold, or Sell?
Based on BM8’s technical indicators, BM8 is a Strong Buy.
    What is BM8’s RSI (14)?
    BM8’s RSI (14) is 57.45, which suggests BM8 is a Neutral.
      What is BM8’s MACD?
      BM8’s MACD is 0.21, which suggests BM8 is a Sell.
        What is BM8’s 5-day moving average?
        BM8’s 5-day moving average is 48.96, which suggests BM8 is a Buy.
          What is BM8’s 20-day moving average?
          BM8 20-day moving average is 48.07, which suggests BM8 is a Buy.
            What is BM8’s 50-day moving average?
            BM8’s 50-day moving average is 48.08, which suggests BM8 is a Buy.
              What is BM8’s 200-day moving average?
              BM8’s 200-day moving average is 48.41, which suggests BM8 is a Buy.
                What is BM8’s Williams % R (14)?
                BM8’s Williams % R (14) is 0.00, which suggests BM8 is a Sell.
                  What is BM8’s CCI (14)?
                  BM8’s CCI (14) is 181.15, which suggests BM8 is a Sell.
                    What is the share price of BioMarin Pharmaceutical?